Clinical Trial Update: Camrelizumab Combined With Local Treatment in NSCLC Patients With BM [Phase 2]

View source ↗

Summary

Phase 2 trial update examining camrelizumab plus local treatment in stage IV non-small cell lung cancer with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: NSCLC Stage IV, Brain Metastases | Phase 2 | Status: UNKNOWN